FIELD: medicine.
SUBSTANCE: invention can be used during treatment of patients with small-cell lung cancer or high-grade form of non-small-cell lung cancer. That is ensured by anticancer therapy and, if there is established an inoperable character of the main process or if the patient refuses to continue chemotherapy or radiotherapy, there is performed symptomatic therapy and prescribe in parallel metformin 2 times a day in a single dose of 500 mg.
EFFECT: invention ensures reduction of lung cancer progression and longer life of patients with lung cancer.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATMENT OF LOCALLY ADVANCED LUNG CANCER OF STAGE IIB-IIIA | 2017 |
|
RU2646513C1 |
| METHOD FOR THERMAL CHEMORADIATION OF ADVANCED NON-SMALL CELL LUNG CANCER | 2014 |
|
RU2548770C1 |
| METHOD OF TREATING ADVANCED NON-SMALL CELL LUNG CANCER | 2014 |
|
RU2559130C1 |
| METHOD OF TREATING UNRESECTABLE PRIMARY LUNG CANCER | 2012 |
|
RU2506974C1 |
| METHOD OF TREATING RECURRENT NON-SMALL CELL LUNG CANCER | 2014 |
|
RU2558473C1 |
| METHOD OF TREATING LOCALLY ADVANCED NON-SMALL-CELL LUNG CANCER | 2012 |
|
RU2489181C1 |
| METHOD FOR COMBINED TREATMENT OF STAGE II-III NON-SMALL-CELL LUNG CANCER | 2017 |
|
RU2636869C1 |
| METHOD FOR COMBINED TREATMENT OF STAGE III NON-SMALL CELL LUNG CANCER USING THERMOCHEMI-RADIOTHERAPY | 2017 |
|
RU2654612C1 |
| METHOD OF COMBINATION TREATMENT OF OPERABLE NON-SMALL CELL LUNG CANCER STAGE III | 2015 |
|
RU2590866C1 |
| METHOD FOR TREATING LUNG CANCER | 2017 |
|
RU2682293C2 |
